Cargando…

Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation

BACKGROUND/AIM: Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Effector T helper cells, mainly Th1 and Th17, cytotoxic T-cells, B-cells, macrophages, microglia, and the cytokines they secrete, are implicated in the initiation and maintenance of a der...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mouzaki, Athanasia, Rodi, Maria, Dimisianos, Nikolaos, Emmanuil, Andreas, Kalavrizioti, Dimitra, Lagoudaki, Rosa, Grigoriadis, Nikolaos C., Papathanasopoulos, Panagiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552669/ https://www.ncbi.nlm.nih.gov/pubmed/26317430 http://dx.doi.org/10.1371/journal.pone.0135434

Ejemplares similares

Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation
por: Mouzaki, Athanasia, et al.
Publicado: (2016)

Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis
por: Dimisianos, Nikolaos, et al.
Publicado: (2014)

Remitting–relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab
por: Mouzaki, Athanasia, et al.
Publicado: (2010)

Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens
por: Rodi, Maria, et al.
Publicado: (2016)

The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians
por: Bakirtzis, Christos, et al.
Publicado: (2018)

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial
por: Messinis, Lambros, et al.
Publicado: (2017)

Phonological Fluency Strategy of Switching Differentiates Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Patients
por: Messinis, L., et al.
Publicado: (2013)

The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials
por: Tsivgoulis, Georgios, et al.
Publicado: (2016)

Smell as a Disease Marker in Multiple Sclerosis
por: Printza, Athanasia, et al.
Publicado: (2022)

Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice
por: Lahiani-Cohen, Inbal, et al.
Publicado: (2020)

Application of antibody phage display to identify potential antigenic neural precursor cell proteins
por: Paspaltsis, Ioannis, et al.
Publicado: (2020)

Asthma in the Elderly: Can We Distinguish It from COPD?
por: Tzortzaki, Eleni G., et al.
Publicado: (2011)

Virus-mediated autoimmunity in Multiple Sclerosis
por: Grigoriadis, Nikolaos, et al.
Publicado: (2006)

Shifting gears: Study of immune system parameters of male habitual marathon runners
por: Panagoulias, Ioannis, et al.
Publicado: (2023)

HIV-1 subtype characteristics of infected persons living in southwestern Greece
por: Davanos, Nikolaos, et al.
Publicado: (2015)

Immunization with Recombinant Prion Protein Leads to Partial Protection in a Murine Model of TSEs through a Novel Mechanism
por: Xanthopoulos, Konstantinos, et al.
Publicado: (2013)

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Cognitive Impairment in Relapsing Remitting and Secondary Progressive Multiple Sclerosis Patients: Efficacy of a Computerized Cognitive Screening Battery
por: Papathanasiou, Athanasios, et al.
Publicado: (2014)

The Role of Diet and Interventions on Multiple Sclerosis: A Review
por: Stoiloudis, Panagiotis, et al.
Publicado: (2022)

Repetitive Transcranial Magnetic Stimulation, Cognition, and Multiple Sclerosis: An Overview
por: Nasios, Grigorios, et al.
Publicado: (2018)

Estimating Everyday Neuropsychological Functioning in Multiple Sclerosis: Reliability and Validity of the Greek Multiple Sclerosis Neuropsychological Questionnaire
por: Konstantinopoulou, Eleni, et al.
Publicado: (2018)

Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis
por: Chalkias, Ioannis-Nikolaos, et al.
Publicado: (2022)

The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse
por: Sragovich, Shlomo, et al.
Publicado: (2019)

Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation
por: Messinis, Lambros, et al.
Publicado: (2018)

Effect of splenectomy on type-1/type-2 cytokine gene expression in a patient with adult idiopathic thrombocytopenic purpura (ITP)
por: Panitsas, Fotios P, et al.
Publicado: (2004)

RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE)
por: Dafou, Dimitra, et al.
Publicado: (2022)

Kinematic and Kinetic Gait Parameters Can Distinguish between Idiopathic and Neurologic Toe-Walking
por: Habersack, Andreas, et al.
Publicado: (2022)

Patterns, Cost, and Immunological Response of MDR vs. Non MDR-Bacteremia: A Prospective Cohort Study
por: Schinas, Georgios, et al.
Publicado: (2023)

Effect of intravitreal injection of aflibercept on blood coagulation parameters in patients with age-related macular degeneration
por: Georgakopoulos, Constantinos D., et al.
Publicado: (2020)

Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center
por: Boziki, Marina, et al.
Publicado: (2021)

Synergistic effect of cold atmospheric pressure plasma and free or liposomal doxorubicin on melanoma cells
por: Pefani-Antimisiari, Konstantina, et al.
Publicado: (2021)

Pure sensory chronic inflammatory polyneuropathy: rapid deterioration after steroid treatment
por: Chroni, Elisabeth, et al.
Publicado: (2015)

How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
por: Rashidbenam, Zahra, et al.
Publicado: (2023)

A case of encapsulating peritoneal sclerosis in a patient with chronic schistosomiasis
por: Fragkou, Paraskevi C., et al.
Publicado: (2021)

The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

Diagnosis and treatment of progressive multiple sclerosis: A position paper
por: Pozzilli, Carlo, et al.
Publicado: (2022)

Cognitive and Language Deficits in Multiple Sclerosis: Comparison of Relapsing Remitting and Secondary Progressive Subtypes
por: Ntoskou, Katerina, et al.
Publicado: (2018)

The Dopamine Imbalance Hypothesis of Fatigue in Multiple Sclerosis and Other Neurological Disorders
por: Dobryakova, Ekaterina, et al.
Publicado: (2015)

Neurological manifestations of long-COVID syndrome: a narrative review
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dlq9hlr20scfp43j232kov4t15